tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market

Jazz Pharmaceuticals (JAZZ) Income Statement

Compare
1,844 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q3 2025), Jazz Pharmaceuticals's total revenue was $1.13B, an increase of 6.74% from the same quarter last year. In Q3, Jazz Pharmaceuticals's net income was $251.41M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 4.07B$ 3.83B$ 3.66B$ 3.09B$ 2.36B
Gross Profit
$ 3.62B$ 3.40B$ 3.12B$ 2.65B$ 2.21B
Operating Expenses
$ 2.91B$ 2.82B$ 3.18B$ 2.48B$ 1.84B
Depreciation and Amortization
$ 660.07M$ 638.70M$ 629.47M$ 552.48M$ 278.25M
EBITDA
$ 1.52B$ 1.45B$ 1.47B$ 1.03B$ 1.04B
Operating Income
$ 716.63M$ 578.58M$ -65.53M$ 170.28M$ 378.07M
Other Income/Expenses
$ -247.94M$ -283.66M$ -317.18M$ -283.83M$ -105.94M
Pretax Income
$ 468.69M$ 294.92M$ -382.70M$ -113.55M$ 272.13M
Net Income
$ 560.12M$ 414.83M$ -224.06M$ -328.95M$ 238.62M
Per Share Metrics
Basic EPS
$ 9.06$ 6.55$ -3.58$ -5.51$ 4.28
Diluted EPS
$ 8.65$ 6.10$ -3.58$ -5.51$ 4.22
Weighted Average Shares Outstanding
61.84M 63.29M 62.54M 59.69M 55.71M
Weighted Average Shares Outstanding (Diluted)
66.01M 72.07M 62.54M 59.69M 56.52M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History